1. Which of the following represents the highest risk period for a medically ill patient to develop a VTE after discharge from the hospital?

2. Which of the following agents would be appropriate for VTE prophylaxis in a high-risk medically ill patient during the hospitalization and continued as extended prophylaxis?

3. Based on published data, what percent of medically ill patients are likely to be eligible for extended VTE prophylaxis?

« Return to Activity